Boston Scientific Corporation (BSX) Rated as a ‘Buy’ at Needham on IVL Market Opportunity

Boston Scientific Corporation (NYSE:BSX) is one of the best beginner stocks to buy, according to analysts. On September 11, analysts at Needham reiterated a ‘Buy’ rating on the stock and a $121 price ... Read More

Boston Scientific aims to consolidate, expand its Minnesota footprints: report

Outside Minneapolis, Boston Scientific has put one of its locations up for sale while expanding another nearby, according to The Minnesota Star Tribune. The medtech is working to consolidate its ... Read More

Boston Scientific, U.S. Physical Therapy, 10x Genomics, GE HealthCare, and Integer Holdings Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation ... Read More

What’s Happening With BSX Stock?

CHONGQING, CHINA - APRIL 20: In this photo illustration, the logo of Boston Scientific Corporation is displayed on a smartphone screen, with the company's branding and slogan Advancing science for ... Read More

Demystifying Boston Scientific: Insights From 9 Analyst Reviews

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target; Steven Lichtman: Oppenheimer: Raises: Outperform: $125.00: $118.00: Danielle Antalffy: UBS: Raise ... Read More

Buy, Sell, Or Hold Boston Scientific Stock At $100?

When assessing Boston Scientific’s valuation against the S&P 500, the stock presents as notably expensive across key metrics. The company’s price-to-sales (P/S) ratio stands at 8.3, substantially ... Read More

Boston Scientific inks $88M Elutia deal to challenge Medtronic

BTIG analysts estimate that Elutia’s Elupro and Medtronic’s TYRX are competing for a $600 million opportunity in the U.S. cardiac rhythm management sector. Read More